Printify
Pickleball Kit (Modern Purple Ribbon)
Pickleball Kit (Modern Purple Ribbon)
Couldn't load pickup availability
Get ready to play with style and support a cause with the Play with Purpose Pickleball Kit. Perfect for both beginners and seasoned players, this kit includes two durable wooden paddles and two plastic balls, all neatly packaged in a transparent, easy-to-carry bag. With customizable prints on both sides, you can bring your unique flair to every game.
More than just a game set, this pickleball kit helps fund an important mission. 40% of all revenue from the Play with Purpose Pickleball Kit goes to Sky Foundation, a non-profit that funds pancreatic cancer research, letting you enjoy your matches while supporting a meaningful cause.
- Includes two wood-constructed paddles with poly-cotton handle fabric
- One size (7.5'' × 15.5'' or 19.05 cm × 39.37 cm) for comfortable handling
- Comes with two plastic balls and a convenient carry bag
- Customizable design on both sides of both paddles
Note: Serve up fun and support pancreatic cancer research with every swing.
Share




Recent News
View all-
Phase 1/2 Trial Launches for Innovative Pancrea...
UCSF researchers begin testing novel TCR-T cell therapy targeting KRAS mutations in advanced pancreatic cancer. A new clinical trial at UCSF has opened to test a first-of-its-kind immunotherapy for advanced...
Phase 1/2 Trial Launches for Innovative Pancrea...
UCSF researchers begin testing novel TCR-T cell therapy targeting KRAS mutations in advanced pancreatic cancer. A new clinical trial at UCSF has opened to test a first-of-its-kind immunotherapy for advanced...
-
FDA Approves NALIRIFOX as First-Line Treatment ...
New frontline treatment offers hope with improved survival outcomes for advanced PDAC patients The U.S. Food and Drug Administration (FDA) has officially approved NALIRIFOX, a new frontline therapy for patients with metastatic...
FDA Approves NALIRIFOX as First-Line Treatment ...
New frontline treatment offers hope with improved survival outcomes for advanced PDAC patients The U.S. Food and Drug Administration (FDA) has officially approved NALIRIFOX, a new frontline therapy for patients with metastatic...
-
Immunotherapy for Pancreatic Ductal Adenocarcin...
Pancreatic ductal adenocarcinoma (PDAC) is one of the deadliest cancers, with a 5-year survival rate under 10%. Standard treatments like surgery and chemotherapy often fail because the cancer usually comes...
Immunotherapy for Pancreatic Ductal Adenocarcin...
Pancreatic ductal adenocarcinoma (PDAC) is one of the deadliest cancers, with a 5-year survival rate under 10%. Standard treatments like surgery and chemotherapy often fail because the cancer usually comes...